<DOC>
	<DOCNO>NCT02389621</DOCNO>
	<brief_summary>The primary purpose study compare efficacy lusutrombopag placebo treatment thrombocytopenia patient chronic liver disease undergo elective invasive procedure .</brief_summary>
	<brief_title>Safety Efficacy Study Lusutrombopag Thrombocytopenia Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<criteria>1 . Able understand study comply study procedure . 2 . Willing provide write informed consent prior Screening . 3 . Male female . 4 . 18 year age old time signing informed consent . 5 . Platelet count &lt; 50 × 10^9/L baseline Day 1 prior randomization . 6 . Undergoing elective invasive procedure . 7 . In opinion investigator , able meet study requirement . 8 . Male patient sterile agree use appropriate method contraception ( include use condom spermicide ) Screening completion Posttreatment Period . 9 . Female patient postmenopausal surgically sterile need agree use highly effective contraception ( include contraceptive implant , injectable contraceptive , combination hormonal contraceptive [ include vaginal ring ] , intrauterine contraceptive device vasectomise partner ) Screening completion Posttreatment Period . Barrier method without spermicide , double barrier contraception oral contraceptive pill insufficient method . 1 . Any following disease : hematopoietic tumor aplastic anemia myelodysplastic syndrome myelofibrosis congenital thrombocytopenia druginduced thrombocytopenia generalized infection require treatment except viral liver disease immune thrombocytopenia . 2 . History splenectomy . 3 . History liver transplantation . 4 . Any following Screening : hepatic encephalopathy uncontrolled drug ascites uncontrolled drug . 5 . Portal vein tumor embolism . 6 . Known positive human immunodeficiency virus . 7 . Past present thrombosis prothrombotic condition ( e.g. , cerebral infarction , myocardial infarction , angina pectoris , coronary artery stent placement , angioplasty , coronary artery bypass grafting , congestive heart failure [ New York Heart Association Grade III/IV ] , arrhythmia know increase risk thromboembolic event [ atrial fibrillation ] , pulmonary thromboembolism , deep vein thrombosis , disseminate intravascular coagulation syndrome ) . 8 . History evidence follow disease : congenital thrombotic disease ( eg , antithrombin deficiency , protein C deficiency , protein S deficiency , coagulation factor [ Factor V Leiden ] mutation ) acquire thrombotic disease ( eg , antiphospholipid antibody syndrome , paroxysmal nocturnal hemoglobinuria , hyperhomocysteinemia , increase factor VIII ) Budd Chiari syndrome . 9 . Portal vein thrombosis base ultrasound , compute tomography ( CT ) , magnetic resonance imaging ( MRI ) within 28 day prior randomization history portal vein thrombosis . 10 . Absence hepatopetal blood flow main trunk portal vein demonstrate Doppler ultrasonography within 28 day prior randomization . 11 . History evidence disease associate risk bleeding ( e.g. , coagulation factor deficiency von Willebrand factor deficiency ) . 12 . Bleeding score randomization ≥ Grade 2 accord World Health Organization ( WHO ) Bleeding Scale . 13 . Any following drug therapy within 90 day prior randomization : anticancer drug interferon preparation radiation therapy exsanguination thrombopoietin receptor agonist investigational agent . 14 . Any invasive procedure within 14 day prior randomization . 15 . Blood transfusion within 14 day prior randomization . 16 . Prior treatment lusutrombopag ( S888711 ) . 17 . Pregnancy lactation . 18 . Known suspected ongoing , active alcohol substance abuse . Patients recent history investigator feel able comply study procedure medication allow participate . 19 . Considered ineligible investigator reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Elective invasive procedure</keyword>
</DOC>